Status:
RECRUITING
Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
Lead Sponsor:
Seoul National University Hospital
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.
Detailed Description
Radiofrequency catheter ablation has become a cornerstone strategy for the rhythm control of AF. During the last decade, catheter technology has revolutionized and, accordingly, clinical outcomes afte...
Eligibility Criteria
Inclusion
- Patients undergoing PVI for PAF
Exclusion
- Aged less than 19 years
- Patients with persistent AF
- Patients with previous ablation or surgery for AF
- Patients with intracardiac thrombus or thromboembolic events within the previous 90 days
- Patients with cardiac surgery or acute coronary syndrome within the previous 90 days
- Patients with contraindication(s) for using oral anticoagulants
- Patients with LA anteroposterior diameter of more than 55 mm
- Patients with left ventricular ejection fraction less than 35%
- Pregnants or those who plan to become pregnant during the study
- Life expectancy less than a year
Key Trial Info
Start Date :
November 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05996159
Start Date
November 7 2023
End Date
September 30 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea